Skip to main content
SpringerLink
Log in
Book cover

Pharmacology of Ocular Therapeutics pp 333–358Cite as

Chemotherapy for Ocular Cancers

  • Chapter
  • First Online:

Abstract

Tumors occur in various locations of ocular structures. They may be benign or malignant. At times the tumors are managed non-surgically using pharmacological agents. Many times chemotherapy is used as an adjunct to surgical excision and enucleation. The prognosis of the ocular tumours solely depends on the early diagnosis, nature and the location of the tumor. This chapter extensively discusses about the clinical features, classification, diagnostic criteria for the ocular tumors and neoplasm, chemotherapeutic agents used in orbital and ocular tumors of childhood like retinoblastoma, drugs used for the treatment for the surface neoplasm and the underlying pharmacological modalities.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aldave AJ, Nguyen A. Ocular surface toxicity associated with topical interferon α-2b. Br J Ophthalmol 2007;91:1087–8.

    Google Scholar 

  • Banavali S. Evidence based management for retinoblastoma. Indian Journal of Medical and Pediatric Oncology 2004;25:35–45.

    Google Scholar 

  • Basti S, Mascai MS. Ocular surface squamous neoplasia. Cornea 2003;22(7):687–704.

    Article  PubMed  Google Scholar 

  • Bazhanova ED. Participation of interferon-alpha in regulation of apoptosis. J Evol Biochem Phys 2005;41(2):127–33.

    Article  CAS  Google Scholar 

  • Bekisz J, Baron S, Balinsky C, Morrow A, dan Zoon KC. Antiproliferative properties of type I and type II interferon. Pharmaceuticals (Basel) 2010;3(4):994–1015.

    Google Scholar 

  • Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol 1984;102(4):598–604.

    Google Scholar 

  • Boehm MD, Huang AJ. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmology 2004;111:1755–61.

    Google Scholar 

  • Boese E, Rogers GM, Kitzmann AS. A very unusual case of ocular surface squamous neoplasia. EyeRounds.org. 14 Feb 2013. Available from: http://EyeRounds.org/cases/163-OSSN.htm. Accessed 22 June 2015.

  • Carreira H, Coutinho F, Carrilho C, Lunet N. HIV and HPV infections and ocular surface squamous neoplasia: systematic review and meta-analysis. Br J Cancer 2013;109(7):1981–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Chabner BA, Bertino J, Cleary J, et al. Cytoxic agents. In: Brunton LL (ed). The pharmacological basis of therapeutics. The McGraw-Hill Companies, Inc. 12th ed, 2011:1665–755.

    Google Scholar 

  • Chantada GL, Guitter MR, Fandino AC, Raslawski EC, de Davila MT, Vaiani E, et al. Treatment results in patients with RB and invasion to cut end of ON. Pediatr Blood cancer 2009;52:218–22.

    Article  PubMed  Google Scholar 

  • Chawla B, Jain A, Azad R. Conservative treatment modalities in retinoblastoma. Indian J Ophthalmol 2013;61(9):479–85. doi: 10.4103/0301-4738.119424. Review. PMID: 24104705

    Google Scholar 

  • Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, Pandey RM. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol 2015 Jun 10. pii: bjophthalmol-2015-306672. doi:10.1136/bjophthalmol-2015-306672. [Epub ahead of print] PMID: 26061162

    Google Scholar 

  • Chiariello M, Gomez E, Gutkind JS. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase. Biochem J. 2000;349(3):869–76.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Chu E, Sartorelli AC Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ (Eds). Basic and Clinical Pharmacology. New York, NY: McGraw-Hill Companies, Inc. 12th ed, 2012: 949–76.

    Google Scholar 

  • Dimaras H, Kimani K, Dimba EAO, Gronsdah P, White A, Chan SL, Gallie BL. Retinoblastoma. Lancet 2012;379:1436–46.

    Article  PubMed  Google Scholar 

  • Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 1994; 117:164–8.

    Google Scholar 

  • Gichuhi S, Sagoo MS, Weiss HA, Burton MJ. Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health 2013;18(12):1424–43.

    Article  PubMed Central  PubMed  Google Scholar 

  • Gichuhi S, Sagoo MS, Ohnuma S, Burton MJ. Pathophysiology of ocular surface squamous neoplasia. Exp Eye Res 2014;129:172–82.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59–67.

    Article  PubMed  Google Scholar 

  • Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993;111:350–6.

    Google Scholar 

  • Holcombe DJ, Lee GA. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia. Am J Ophthalmol 2006;142(4):568–71.

    Article  PubMed  CAS  Google Scholar 

  • Hurwitz RL, Shields CL, Shields JA, Cheves-Barrios P, Gombos D, Hurwitz MY, Chintagumpala MM. Retinoblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practices of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 809–37.

    Google Scholar 

  • de Keizer RJ, de Wolff-Rouendaal D, van Delft JL. Topical application of 5-fluorouracil in premalignant lesions of cornea: conjunctiva and eyelid. Doc Ophthalmol 1986;64(1):31–42.

    Google Scholar 

  • Kieval JZ, Karp CL, Abou Shousha M, Galor A, Hoffman RA, Dubovy SR, et al. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. Ophthalmology 2012;119(3):481–6.

    Google Scholar 

  • Kiire CA, Srinivasan S, Karp CL. Ocular surface squamous neoplasia. Int Ophthal Mol Clin 2010;50(3):35–46.

    Article  Google Scholar 

  • Kim JW, Abramson DH. Topical treatment options for conjunctival neoplasms. Clin Ophthalmol 2008;2(3):503–15.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Kruh GD. Lustrous insights into cisplatin accumulation: copper transporters. Clin Cancer Res 2003;9:5807–9.

    PubMed  CAS  Google Scholar 

  • Lee GA, Hirst LW. Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year survey. Arch Ophthalmol 1992;110:525–7.

    Article  PubMed  CAS  Google Scholar 

  • Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol 1995;39(6):429–50.

    Article  PubMed  CAS  Google Scholar 

  • Linn Murphree A. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol Clin North Am 2005;18:41–53.

    Google Scholar 

  • Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol 1994;112(9):1145–6

    Google Scholar 

  • Midena E, Boccato P, Angeli CD. Conjunctival squamous cell carcinoma treated with topical 5- fluorouracil. Arch Ophthalmol 1997;115(12):1600–1.

    Article  PubMed  CAS  Google Scholar 

  • Midena E, Angeli CD, Valenti M, et al. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol 2000;84(3):268–72.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Nagaiah G, Stotler C, Orem J, Mwanda WO, Remicka SC. Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa. Curr Opin Oncol 2010;22(5):437–42.

    Article  PubMed Central  PubMed  Google Scholar 

  • Nemet AY, Sharma V, and Benger R. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C. Clin Exp Ophthalmol 2006;34:375–7.

    Google Scholar 

  • Panda A, Pe’er J, Aggarwal A, et al. Effect of topical mitomycin C on corneal endothelium. Am J Ophthalmol 2008;145(4):635–8.

    Article  PubMed  CAS  Google Scholar 

  • Papaioannou IT, Melachrinou MP, Drimtzias EG, Gartaganis SP. Corneal-conjunctival squamous cell carcinoma. Cornea 2008;27(8):957–8.

    Article  PubMed  Google Scholar 

  • Parrozzani R, Lazzarini D, Alemany-Rubio E, Urban F, Midena E. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study. Br J Ophthalmol 2011;95(3):355–9. doi: 10.1136/bjo.2010.183244. Epub 2010 Aug 7.

    Google Scholar 

  • Pe’er J. Ocular surface squamous neoplasia. Ophthalmol Clin North Am. 2005;18(1):1–13.

    Article  PubMed  Google Scholar 

  • Pizzarello LD, Jakobiec FA. Bowen’s disease of the conjunctiva: a misnomer. In: Jakobiec FA, editor. Ocularand adnexal tumors. Birmingham: Aesculapius; 1978. p. 553–71.

    Google Scholar 

  • Poothullil AM, Colby KA. Topical medical therapies for ocular surface tumors. Semin Ophthalmol 2006;21:161–9.

    Google Scholar 

  • Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol 1995;113:1041–4.

    Google Scholar 

  • Rodriguez-Galindo C. Chemotherapy management in retinoblastoma. In: Rodriguez-Galindo C, Wilson MW (eds). Retinoblastoma. Springer, New York. 1st ed. 2010:67–73.

    Google Scholar 

  • Rudkin AK, Dodd T, Muecke JS. The differential diagnosis of localized amelanotic limbal lesions: a review of 162 consecutive excisions. Br J Ophthalmol 2011;95:350–4.

    Article  PubMed  Google Scholar 

  • Rudkin AK, Muecke JS. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol 2011;95(7):947–50. doi:10.1136/bjo.2010.186171. Epub 2011 Jan 20.

    Google Scholar 

  • Sepulveda R, Pe’er J, Midena E, Seregard S, Dua HS, Singh AD. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmol 2010;94(5):532–5. doi: 10.1136/bjo.2009.160820. Epub 2009 Sep 23. Review. PMID: 19776089

    Google Scholar 

  • Shields CL, Shields JA, Baez KA, Cater JR, Potter P. Choroial invasion of RB: metastatic and clinical risk factors. Br J Ophthalmol 1993;77:544–8.

    Google Scholar 

  • Shields JA, Shields CL. Pediatric ocular and periocular tumors. Pediatr Ann 2001;30:491–501.

    Google Scholar 

  • Shields CL, Kaliki S, Kim HJ, Al-Dahmash S, Shah SU, Lally SE, Shields JA. Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification. Cornea. 2013;32(3):248–56.

    Google Scholar 

  • Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003;22(47):7265–79.

    Article  PubMed  CAS  Google Scholar 

  • Sturges A, Butt AL, Lai JE, Chodosh J. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology 2008;115(8):1297–302, 1302.e1. doi: 10.1016/j.ophtha.2008.01.006. Epub 2008 Feb 21.

    Google Scholar 

  • Tagliaferri P, Caraglia M, Budillon A, et al. New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancer. Cancer Immunol Immunother 2005;54(1):1–10.

    Article  PubMed  CAS  Google Scholar 

  • Tananuvat N, Lertprasertsuke N. Ocular Surface Squamous Neoplasia. In: Srivastava S, editor. Intraepithelial neoplasia. Publisher InTech. Published online 08 Feb 2012. Published in print edition February; 2012. www.intechopen.com. p. 35–62.

    Google Scholar 

  • Tananuvat N, Lertprasertsuk N, Mahanupap P, Noppanakeepong P. Role of impression cytology in diagnosis of ocular surface neoplasia. Cornea 2008;27:269–74.

    Article  PubMed  Google Scholar 

  • Tripathi KD. Chemotherapy of neoplastic diseases. In: Essentials of medical pharmacology. 6th ed. New Delhi: Jaypee Brothers Medical Publishers 2008; p. 819–34.

    Google Scholar 

  • Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology 1999;106:91–7.

    Google Scholar 

  • Velpandian T, Saluja V, Ravi AK, Kumari SS, Mathur R, Biswas NR, Ghose S. Evaluation of the stability of extemporaneously prepared ophthalmic formulation of mitomycin C. J Ocul Pharmacol Ther. 2005;21(3):217–21.

    Article  PubMed  CAS  Google Scholar 

  • Xu Y, Zhou Z, Xu Y, Wang M, Liu F, Qu H, et al. The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia. Eye (Lond) 2012;26(6):781–7.

    Article  CAS  Google Scholar 

  • Yeatts RP, Engelbrecht NE, Curry CD, et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 2000;107(12):2190–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ocular Oncology and Pediatric Ophthalmology Service, Dr. Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India

    Bhavna Chawla MS (Ophthalmol)

  2. Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India

    Rachna Seth MD

  3. Ocular Pharmacology and Pharmacy, Dr. Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India

    Laxmi Moksha MPharm

Authors
  1. Bhavna Chawla MS (Ophthalmol)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachna Seth MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laxmi Moksha MPharm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bhavna Chawla MS (Ophthalmol) .

Editor information

Editors and Affiliations

  1. Ocular Pharmacology and Pharmacy, Dr. RP Centre for Ophthalmic Sciences, New Delhi, India

    Thirumurthy Velpandian

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Chawla, B., Seth, R., Moksha, L. (2016). Chemotherapy for Ocular Cancers. In: Velpandian, T. (eds) Pharmacology of Ocular Therapeutics. Adis, Cham. https://doi.org/10.1007/978-3-319-25498-2_12

Download citation

Publish with us

Policies and ethics

Search

Navigation